Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jan 9;9(6):6977–6992. doi: 10.18632/oncotarget.24059

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2018 Phan et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Correlation between expression of CDCA5 in RFS breast cancer patient (A-I). Breast cancer patient had significant shorter RFS with high expression of CDCA5 (A). High expression of CDCA5 was significantly associated with shorter RFS in ER positive but good prognosis in ER negative (B, C). In both luminal A and luminal B, high expression of CDCA5 was significantly indicated shorter value (E, F). High expression of CDCA3 was not significantly linked to longer RFS in HER2 positive but not in basal subtype (D, G). Patient underwent chemotherapy had longer RFS relative to those who did not received chemotherapy treatment (H, I). P-value<0.05 means significant different.